Author Search Results :: UTM Library Massive Scholar Tracking

1

A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy by Masatoshi Kudo

Published 2020-03-01

Get full text

Article
2

Current Therapeutic Strategies for Hepatocellular Carcinoma in Japan by Masatoshi Kudo

Published 2023-10-01

Get full text

Article
3

Limited Impact of Anti-PD-1/PD-L1 Monotherapy for Hepatocellular Carcinoma by Masatoshi Kudo

Published 2020-10-01

Get full text

Article
4

Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma? by Masatoshi Kudo

Published 2021-07-01

Get full text

Article
5

Selection of Systemic Treatment Regimen for Unresectable Hepatocellular Carcinoma: Does Etiology Matter? by Masatoshi Kudo

Published 2022-06-01

Get full text

Article
6

A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion by Masatoshi Kudo

Published 2021-10-01

Get full text

Article
7

Combination Immunotherapy with Anti-PD-1/PD-L1 Antibody plus Anti-VEGF Antibody May Promote Cytotoxic T Lymphocyte Infiltration in Hepatocellular Carcinoma, Including in the Noninf... by Masatoshi Kudo

Published 2022-05-01

Get full text

Article
8

Recent Advances in Systemic Therapy for Hepatocellular Carcinoma in an Aging Society: 2020 Update by Masatoshi Kudo

Published 2020-11-01

Get full text

Article
9

All Stages of HCC Patients Benefit from Systemic Therapy Combined with Locoregional Therapy by Masatoshi Kudo

Published 2023-08-01

Get full text

Article
10

Prioritized Requirements for First-Line Systemic Therapy for Hepatocellular Carcinoma: Broad Benefit with Less Toxicity by Masatoshi Kudo

Published 2023-01-01

Get full text

Article
11

Adjuvant Immunotherapy after Curative Treatment for Hepatocellular Carcinoma by Masatoshi Kudo

Published 2021-09-01

Get full text

Article
12

Implications of the TACTICS Trial: Establishing the New Concept of Combination/Sequential Systemic Therapy and Transarterial Chemoembolization to Achieve Synergistic Effects by Masatoshi Kudo

Published 2022-10-01

Get full text

Article
13

A Paradigm Change in the Treatment Strategy for Hepatocellular Carcinoma by Masatoshi Kudo

Published 2020-06-01

Get full text

Article
14

Nivolumab plus Ipilimumab: A Novel First-Line Combination Immunotherapy for Unresectable Hepatocellular Carcinoma by Masatoshi Kudo

Published 2024-08-01

Get full text

Article
15

A Changing Role of TACE in the Era of ICI plus Anti-VEGF/TKI plus TACE: From Total Embolization to Partial Embolization (Immune Boost TACE) by Masatoshi Kudo

Published 2024-05-01

Get full text

Article
16

Objective Response to Systemic Therapy Is a Strong Predictor of Overall Survival in Patients with Unresectable Hepatocellular Carcinoma by Masatoshi Kudo

Published 2023-11-01

Get full text

Article
17

Surveillance, Diagnosis, and Treatment Outcome of Hepatocellular Carcinoma in Japan: 2023 Update by Masatoshi Kudo

Published 2023-03-01

Get full text

Article
18

Adjuvant Atezolizumab-Bevacizumab after Resection or Ablation for Hepatocellular Carcinoma by Masatoshi Kudo

Published 2023-05-01

Get full text

Article
19

Challenges in Adjuvant Immunotherapy after Resection or Ablation for High-Risk Hepatocellular Carcinoma at High-Risk of Recurrence by Masatoshi Kudo

Published 2024-10-01

Get full text

Article
20

Newly Developed Modified ALBI Grade Shows Better Prognostic and Predictive Value for Hepatocellular Carcinoma by Masatoshi Kudo

Published 2021-12-01

Get full text

Article

1
2
3
4
5
6
7
8
9
Next
[9]